Loading company…
Raziel Therapeutics Ltd., founded in 2012 in Jerusalem, develops drugs for obesity and related indications.
Founded in 2012 and based in Jerusalem, Israel, Raziel Therapeutics Ltd. is a pharmaceutical company developing drugs for obesity and related indications. Its product, RZL-012, causes fat cell death at the injection site, which reduces fat tissue.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in